BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 36119461)

  • 1. Clinical Characteristics and Prognostic Factors in Primary Breast Diffuse Large B-Cell Lymphoma.
    Chen GL; Li D; Cao S; Jiang S; Zhang Q; Jin J; Xia Z; Liu Y; Liu X; Zhu Y; Chen Y; Gu L; Hong X; Cao J; Tao R; Lv F
    Mediterr J Hematol Infect Dis; 2022; 14(1):e2022066. PubMed ID: 36119461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting central nervous system relapse in primary breast diffuse large B-cell lymphoma using the stage-modified IPI score: A retrospective cohort study.
    Chen GL; Guo P; Wang J; Yu BH; Hong X; Cao J; Lv F
    Heliyon; 2024 Mar; 10(5):e26795. PubMed ID: 38439878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary breast diffuse large B-cell lymphoma characterized by CNS relapse and successful hematopoietic stem cell transplantation salvage therapy.
    Chan CY; Ou CW; Chang H; Kuo MC; Lin TL; Hung YS; Wu JH; Shih LY; Kao HW
    J Formos Med Assoc; 2024 Jan; ():. PubMed ID: 38296697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characteristics and outcomes of patients with diffuse large B cell lymphoma treated with R-CHOP-like or CHOP-like regimens: an 8-year experience from a single center.
    Huang H; Fan L; Fu D; Lin Q; Shen J
    Ann Palliat Med; 2020 Jul; 9(4):1442-1452. PubMed ID: 32648457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Outcomes of Diffuse Large B-cell Lymphoma Patients with Synchronous and Early Central Nervous System Involvement: A Single-Center Experience.
    Al-Mansour M; Saif SA; Alharbi Z; Alhwaity AS; Almasrahi A; Alnejadi W; Hussain S; Aga SS; Khan MA; Almufti R; Absi A
    Asian Pac J Cancer Prev; 2023 Feb; 24(2):623-631. PubMed ID: 36853313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of different staging systems and prognostic analysis of 110 primary gastrointestinal diffuse large B cell lymphoma].
    Mao L; Wang X; Wang CY; Xia B; Ning QY; Yang HL; Yu Y; Zhang YZ
    Zhonghua Yi Xue Za Zhi; 2019 Jun; 99(24):1853-1858. PubMed ID: 31269579
    [No Abstract]   [Full Text] [Related]  

  • 7. A multicentre study of primary breast diffuse large B-cell lymphoma in the rituximab era.
    Hosein PJ; Maragulia JC; Salzberg MP; Press OW; Habermann TM; Vose JM; Bast M; Advani RH; Tibshirani R; Evens AM; Islam N; Leonard JP; Martin P; Zelenetz AD; Lossos IS
    Br J Haematol; 2014 May; 165(3):358-63. PubMed ID: 24467658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Central Nervous System International Prognostic Index on the Treatment of Diffuse Large B Cell Lymphoma.
    Ma'koseh M; Tamimi F; Abufara A; Abusalem L; Salama O; Saleh Y; Khader R; Faiyoumi BA; Al-Rwashdeh M; Halahleh K
    Cureus; 2021 Aug; 13(8):e16802. PubMed ID: 34513408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical prognostic risk analysis and progression factor exploration of primary breast lymphoma.
    Deng J; Mi L; Wang X; Zhu J; Zhang C; Song Y
    Hematology; 2022 Dec; 27(1):1272-1281. PubMed ID: 36476227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A comparative study of induction chemotherapy with or without autologous hematopoietic stem cell transplantation in the treatment of newly diagnosed young medium/high risk diffuse large B cell lymphoma patients].
    Wang X; Xia B; Wang CY; Li MZ; Xu W; Yuan T; Tian C; Zhao HF; Yang HL; Zhao ZG; Wang XF; Wang YF; Yu Y; Zhang YZ
    Zhonghua Xue Ye Xue Za Zhi; 2019 Feb; 40(2):117-124. PubMed ID: 30831626
    [No Abstract]   [Full Text] [Related]  

  • 11. Primary breast diffuse large B-cell lymphoma in the rituximab era: Therapeutic strategies and patterns of failure.
    Hu S; Song Y; Sun X; Su L; Zhang W; Jia J; Bai O; Yang S; Liang R; Li X; Zhang H; Gao Y; Zhang W; Xiao X; Bao H; Wang N; Ren H; Cen X; Yang S; Zhao Y; Wang Y; Wang Y; Liu A; Wang J; Shi Y; Yuan M; Li Y; He X
    Cancer Sci; 2018 Dec; 109(12):3943-3952. PubMed ID: 30302857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical prognostic factors of diffuse large B cell non-Hodgkin lymphoma: a retrospective study.
    Abdelhamid T; Samra M; Ramadan H; Mehessin M; Mokhtar N
    J Egypt Natl Canc Inst; 2011 Mar; 23(1):17-24. PubMed ID: 22099932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Significance of LDH Ratio in Serum/Cerebral Spinal Fluid of Patients with Primary Testicular Diffuse Large B-Cell Lymphoma.
    Liu YZ; Luo P; Liu C; Xue K; Jin J; Xia ZG; Liu XJ; Zhang QL; Cao JN; Hong XN; Lv FF
    Onco Targets Ther; 2019; 12():10469-10475. PubMed ID: 31819527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prognosis analysis of primary breast diffuse large B cell lymphoma].
    Zhu YH; Meng WJ; He LH; Jia YS; Tong ZS
    Zhonghua Zhong Liu Za Zhi; 2019 Mar; 41(3):235-240. PubMed ID: 30917462
    [No Abstract]   [Full Text] [Related]  

  • 15. Impact of initial chemotherapy cycles and clinical characteristics on outcomes for HIV-associated diffuse large B cell lymphoma patients: The Central and Western China AIDS Lymphoma League 001 study (CALL-001 study).
    Wang C; Wu Y; Liu J; Min H; Huang Y; Wei G; Zhang W; Wang M; Tang X; Zhou H; Chen Y; Liu Y
    Front Immunol; 2023; 14():1153790. PubMed ID: 37063928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD5 positivity is an independent adverse prognostic factor in elderly patients with diffuse large B cell lymphoma.
    Chuang WY; Chang H; Shih LY; Wang PN; Chang YS; Lin TL; Hung YS; Yeh CJ; Ueng SH; Tang TC; Kuo MC; Dunn P; Wu JH; Kao HW; Ou CW; Wan YL; Hsueh C
    Virchows Arch; 2015 Nov; 467(5):571-82. PubMed ID: 26369546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New risk factors and new tendency for central nervous system relapse in patients with diffuse large B-cell lymphoma: a retrospective study.
    Cai QQ; Hu LY; Geng QR; Chen J; Lu ZH; Rao HL; Liu Q; Jiang WQ; Huang HQ; Lin TY; Xia ZJ
    Chin J Cancer; 2016 Sep; 35(1):87. PubMed ID: 27624700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A retrospective analysis of clinical characteristics and prognostic factors for 124 cases of primary gastric lymphomas].
    He Y; Wang L; Zhu HY; Liang JH; Wu W; Wu JZ; Xia Y; Cao L; Fan L; Li JY; Xu W
    Zhonghua Xue Ye Xue Za Zhi; 2017 Jun; 38(6):505-510. PubMed ID: 28655094
    [No Abstract]   [Full Text] [Related]  

  • 19. A multicentre retrospective study of primary breast diffuse large B-cell and high-grade B-cell lymphoma treatment strategies and survival.
    Zhang T; Zhao H; Cui Z; Xu H; Liu X; Wu Y; Li Y; Sun S; Wang P; Wang Y; Shi X
    Hematology; 2020 Dec; 25(1):203-210. PubMed ID: 32476626
    [No Abstract]   [Full Text] [Related]  

  • 20. Central Nervous System Involvement in Patients with Diffuse Large B Cell Lymphoma: Analysis of the Risk Factors and Prognosis from a Single-Center Retrospective Cohort Study.
    Ma J; Li Q; Shao J; Ma Y; Lin Z; Kang H; Chen B
    Cancer Manag Res; 2019; 11():10175-10185. PubMed ID: 31819650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.